Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2021 Filed Feb 5, 2021 20:27 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionStock Appreciation Right · Derivative | 50,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-21-008346 · doc4.xml · derivative · entry 9 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:27 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 22,848 | $173.12 | $3,955,445.76 |
DisclosureSEC source: 0001209191-21-008346 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,778 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:27 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 50,000 | $22.95 | $1,147,500.00 |
DisclosureSEC source: 0001209191-21-008346 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:27 UTC | GrantStock Appreciation Right · Derivative | 130,720 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008345 · doc4.xml · derivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,720 Underlying: Common Stock · 130,720 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
|
| February 03, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
GrantStock Appreciation Right · Derivative | 27,190 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,190 Underlying: Common Stock · 27,190 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GrantStock Appreciation Right · Derivative | 27,190 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · derivative · entry 10 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,190 Underlying: Common Stock · 27,190 shares Expires 2031-02-03 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantStock Appreciation Right · Derivative | 8,370 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008342 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 8,370 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
GrantStock Appreciation Right · Derivative | 20,920 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · derivative · entry 8 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,920 Underlying: Common Stock · 20,920 shares Expires 2031-02-03 F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 17,000 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · derivative · entry 7 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,930 Underlying: Common Stock · 17,000 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 20,490 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · derivative · entry 6 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,490 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 7,574 | $171.17 | $1,296,405.98 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · nonDerivative · entry 4 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,975.2542 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.90 to $171.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 23,772 | $173.12 | $4,115,408.64 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · nonDerivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,549.2542 F1 · balance_after: Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 17,000 | $81.96 | $1,393,320.00 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,321.2542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 20,490 | $69.58 | $1,425,694.20 |
DisclosureSEC source: 0001209191-21-008341 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,321.2542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:24 UTC |
Cohen Jeffrey E.SVP-Government Relations
|
GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008339 · doc4.xml · derivative · entry 1 Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:23 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008337 · doc4.xml · derivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:22 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
GrantStock Appreciation Right · Derivative | 15,690 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008336 · doc4.xml · derivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 17:12 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 1,266 | $155.00 | $196,230.00 |
DisclosureSEC source: 0001209191-20-060650 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,484 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · derivative · entry 7 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2029-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 3,432 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · derivative · entry 6 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,865 Underlying: Common Stock · 3,432 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 1,605 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · derivative · entry 5 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Underlying: Common Stock · 1,605 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Tax withholdingCommon Stock | 5,771 | $153.03 | $883,136.13 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · nonDerivative · entry 4 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 2,000 | $139.06 | $278,120.00 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · nonDerivative · entry 3 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 3,432 | $101.16 | $347,181.12 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · nonDerivative · entry 2 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:02 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 1,605 | $81.96 | $131,545.80 |
DisclosureSEC source: 0001209191-20-059529 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:21 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 5,078 | $151.75 | $770,586.50 |
DisclosureSEC source: 0001209191-20-058919 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,484 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 44,750 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · derivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,750 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Tax withholdingCommon Stock | 24,257 | $151.82 | $3,682,697.74 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · nonDerivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,420.7241 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionCommon Stock | 44,750 | $37.18 | $1,663,805.00 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,677.7241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 3,770 | $151.75 | $572,097.50 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 8 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:18 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058916 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,241.2235 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:18 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
SaleCommon Stock | 7,868 | $151.75 | $1,193,969.00 |
DisclosureSEC source: 0001209191-20-058916 · doc4.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358.2235 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 17,002 | $149.50 | $2,541,799.00 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,927.7241 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By DJP 2020 Trust Disclosed balance after: 57,802 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058918 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 319 | $149.47 | $47,680.93 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 7 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 63,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · by RJP 2020 Trust Disclosed balance after: 63,999 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 63,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By PMP 2020 Trust Disclosed balance after: 64,000 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:18 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
SaleCommon Stock | 1,350 | $149.75 | $202,162.50 |
DisclosureSEC source: 0001209191-20-058916 · doc4.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,226.2235 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,089 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 20:20 UTC |
Paslick P. MartinSVP and CIO
|
GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 63,999 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 6 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By JBP 2020 Trust Disclosed balance after: 57,802 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,929.7241 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,802 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 7,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,731.7241 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 20:40 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 6,536 | $154.46 | $1,009,536.83 |
DisclosureSEC source: 0001209191-20-058188 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,517 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.16 to $154.49, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 6 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By LCF Trust (Reporting Person, Trustee) Disclosed balance after: 44,039 Read SEC document |
| November 10, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 5 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.